Mergers & Acquisitions ·
Aurora Cannabis filed a 6-K to release a news refuting inaccurate statements made by Curaleaf Holdings in support of…
ACBAurora Cannabis Inc
Aurora Cannabis filed a 6-K to release a news refuting inaccurate statements made by Curaleaf Holdings in support of its unsolicited hostile takeover bid. Aurora's Board, assisted by a Special Committee, is reviewing the proposal and advised shareholders to take no action pending a formal recommendation. The company highlighted that international net revenue grew 17% year-over-year in fiscal Q1'27, driven by strong performance in Germany where reimbursement changes impacted less than 10 percent of volume. Aurora also noted record global medical cannabis revenue and adjusted EBITDA for FY2026, alongside an August 19 acquisition of Internode Pharma Limited and HAP Pharma Limited to expand UK distribution. The company operates in the global medical cannabis industry.